Manchester Capital Management’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$570 Hold
8
﹤0.01% 1219
2025
Q4
$474 Buy
+8
New +$434 ﹤0.01% 1268
2025
Q2
Sell
-83
Closed -$3.29K 1221
2025
Q1
$3.29K Hold
83
﹤0.01% 951
2024
Q4
$3.38K Hold
83
﹤0.01% 938
2024
Q3
$3.24K Hold
83
﹤0.01% 952
2024
Q2
$3.63K Hold
83
﹤0.01% 886
2024
Q1
$3.96K Hold
83
﹤0.01% 761
2023
Q4
$3.92K Hold
83
﹤0.01% 736
2023
Q3
$3.95K Hold
83
﹤0.01% 684
2023
Q2
$4.83K Buy
+83
New +$4.98K ﹤0.01% 621

Other funds holding NGVT

Manchester Capital Management's NGVT Position: Q1 2026 in Review

Manchester Capital Management held its Ingevity (NGVT) position steady in Q1 2026 at 8 shares worth $570. The position accounts for ﹤0.01% of the portfolio, ranked #1219.

Manchester Capital Management first reported a position in NGVT in Q2 2023 and has held it in 10 quarters since. The position peaked at $4.83K in Q2 2023. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Manchester Capital Management held 8 shares of Ingevity worth $570 as of Q1 2026.
  • Manchester Capital Management left its Ingevity share count unchanged in Q1 2026.
  • Ingevity made up ﹤0.01% of Manchester Capital Management's portfolio in Q1 2026, its #1219 holding.
  • Manchester Capital Management first reported a position in Ingevity in Q2 2023 and has held it in 10 quarters since.
  • Manchester Capital Management's Ingevity position peaked at $4.83K in Q2 2023.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.